Ogata T, Araki K, Matsuura K, Kobayashi M, Inomata T, Yasuhiro O, Yoshida S
Department of Surgery, Kochi Medical School, Japan.
Int J Radiat Oncol Biol Phys. 1995 May 15;32(2):341-7. doi: 10.1016/0360-3016(94)00479-5.
To improve the prognosis of gastric cancer, radical surgical resection with extensive lymph node dissection plus intraoperative radiation therapy (IORT) was tried in our clinic. In addition, a new operative procedure was created to obtain wider irradiation field for total gastrectomy patients.
A total of 183 gastric cancer patients who underwent radical gastrectomy with or without IORT from August 1983 to July 1992 were retrospectively evaluated. The patients were divided into two groups: group 1 consisted of 58 patients who underwent radical operation plus IORT. A single dose of 28 to 30 Gy was delivered around the celiac axis with an electron beam of 12 MeV. Group 2, our historical control group, which showed no difference in age, sex and stage, consisted of 120 patients who underwent only radical surgery. In addition, a new method of total gastrectomy with IORT after mobilization of the tail and body of the pancreas was devised to get wider irradiation field for advanced gastric cancer.
Of the Stage II gastric cancer patients, all the 11 patients of group 1 are alive, whereas in group 2, the 4-year and the 8-year survival rates were 60% and 48%, respectively. In Stage III patients, the 8-year survival rate of group 1 was 55% vs. 35% in group 2. As for Stage IV patients, the 5-year survival rate of group 1 was 12% and that of group 2 was 13%.
Using this combined treatment modality of radical surgical operation+IORT, improved survival rates were obtained for Stage II and III gastric cancer patients. However, the method was ineffective for more advanced, Stage IV, patients. The wider irradiation field method used for total gastrectomy patients was safe and no complications were encountered.
为改善胃癌预后,我院尝试了根治性手术切除加广泛淋巴结清扫及术中放疗(IORT)。此外,还创建了一种新的手术方法,以扩大全胃切除术患者的照射野。
回顾性评估了1983年8月至1992年7月期间183例行根治性胃切除术且接受或未接受IORT的胃癌患者。患者分为两组:第1组由58例行根治性手术加IORT的患者组成。用12 MeV电子束在腹腔动脉周围给予单次剂量28至30 Gy照射。第2组为历史对照组,在年龄、性别和分期上无差异,由120例仅接受根治性手术的患者组成。此外,设计了一种在游离胰体尾后行全胃切除术加IORT的新方法,以扩大进展期胃癌的照射野。
在II期胃癌患者中,第1组的11例患者均存活,而在第2组中,4年和8年生存率分别为60%和48%。在III期患者中,第1组的8年生存率为55%,而第2组为35%。至于IV期患者,第1组的5年生存率为12%,第2组为13%。
采用根治性手术+IORT这种联合治疗方式,II期和III期胃癌患者的生存率得到了提高。然而,该方法对更晚期的IV期患者无效。用于全胃切除术患者的扩大照射野方法是安全的,未出现并发症。